This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Richardson, M. A. Articles by Singletary, S. E. Search for Related Content PubMed PubMed Citation Articles by Richardson, M. A. Articles by Singletary, S. E. Social Bookmarking                            What's this?

Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology

From the Centers for Alternative Medicine Research and Health Promotion Research and Development, The University of Texas-Houston School of Public Health; Departments of Biostatistics and Surgical Oncology, The University of Texas M.D. Anderson Cancer Center; and Section of Health Services Research, Baylor College of Medicine, Houston, TX.

Address reprint requests to Mary Ann Richardson, DrPH, National Institutes of Health, National Center for Complementary and Alternative Medicine, 31 Center Dr, Room 5B-58, Bethesda, MD 20892-2182; email marich@ od.nih.gov.

PURPOSE: Oncologists are aware that their patients use complementary/alternative medicine (CAM). As cancer incidence rates and survival time increase, use of CAM will likely increase. This study assessed the prevalence and predictors of CAM use in a comprehensive cancer center.

SUBJECTS AND METHODS: Subjects were English-speaking cancer patients at least 18 years of age, attending one of eight outpatient clinics at The University of Texas M.D. Anderson Cancer Center, Houston, TX, between December 1997 and June 1998. After giving written informed consent, participants completed a self-administered questionnaire. Differences between CAM users and nonusers were assessed by ² and univariate logistic regression analysis. A multivariate logistic regression model identified the simultaneous impact of demographic, clinical, and treatment variables on CAM use; P values were two-sided.

RESULTS: Of the 453 participants (response rate, 51.4%), 99.3% had heard of CAM. Of those, 83.3% had used at least one CAM approach. Use was greatest for spiritual practices (80.5%), vitamins and herbs (62.6%), and movement and physical therapies (59.2%) and predicted (P < .001) by sex (female), younger age, indigent pay status, and surgery. After excluding spiritual practices and psychotherapy, 95.8% of participants were aware of CAM and 68.7% of those had used CAM. Use was predicted (P < .0001) by sex (female), education, and chemotherapy.

CONCLUSION: In most categories, CAM use was common among outpatients. Given the number of patients combining vitamins and herbs with conventional treatments, the oncology community must improve patient-provider communication, offer reliable information to patients, and initiate research to determine possible drug-herb-vitamin interactions.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				E. B. Golden, P. Y. Lam, A. Kardosh, K. J. Gaffney, E. Cadenas, S. G. Louie, N. A. Petasis, T. C. Chen, and A. H. Schonthal Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors Blood, June 4, 2009; 113(23): 5927 - 5937. [Abstract] [Full Text] [PDF]

				J. L. Oliffe, B. J. Davison, T. Pickles, and L. Mroz The Self-Management of Uncertainty Among Men Undertaking Active Surveillance for Low-Risk Prostate Cancer Qual Health Res, April 1, 2009; 19(4): 432 - 443. [Abstract] [PDF]

				A. Eustachi, H. Pajtler, K. Linde, D. Melchart, and W. Weidenhammer Patients of an Interdisciplinary Cancer Treatment Center: Use of, Knowledge About, and Demand for CAM Treatment Options Integr Cancer Ther, March 1, 2009; 8(1): 56 - 62. [Abstract] [PDF]

				A.-F. Hsiao, M. D. Wong, M. F. Miller, A. H. Ambs, M. S. Goldstein, A. Smith, R. Ballard-Barbash, L. S. Becerra, E. M. Cheng, and N. S. Wenger Role of Religiosity and Spirituality in Complementary and Alternative Medicine Use Among Cancer Survivors in California Integr Cancer Ther, September 1, 2008; 7(3): 139 - 146. [Abstract] [PDF]

				M. H Hanigan, B. L dela Cruz, D. M Thompson, K. C Farmer, and P. J Medina Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: questionnaire validation Journal of Oncology Pharmacy Practice, September 1, 2008; 14(3): 123 - 130. [Abstract] [PDF]

				R. T. Lee, F. J. Hlubocky, J.-J. Hu, R. S. Stafford, and C. K. Daugherty An International Pilot Study of Oncology Physicians' Opinions and Practices on Complementary and Alternative Medicine (CAM) Integr Cancer Ther, June 1, 2008; 7(2): 70 - 75. [Abstract] [PDF]

				E. L. Archer and D. K. Boyle Herb and Supplement Use Among the Retail Population of an Independent, Urban Herb Store J Holist Nurs, March 1, 2008; 26(1): 27 - 35. [Abstract] [PDF]

				S.-G. Kim, E.-C. Park, J.-H. Park, M.-I. Hahm, J.-H. Lim, and K.-S. Choi Initiation and Discontinuation of Complementary Therapy Among Cancer Patients J. Clin. Oncol., November 20, 2007; 25(33): 5267 - 5274. [Abstract] [Full Text] [PDF]

				A. M. Gross, Q. Liu, and S. Bauer-Wu Prevalence and Predictors of Complementary Therapy Use in Advanced-Stage Breast Cancer Patients J. Oncol. Pract, November 1, 2007; 3(6): 292 - 295. [Abstract] [Full Text] [PDF]

				Ling Xu, Li Xing Lao, A. Ge, Shan Yu, Jie Li, and P. J. Mansky Chinese Herbal Medicine for Cancer Pain Integr Cancer Ther, September 1, 2007; 6(3): 208 - 234. [Abstract] [PDF]

				B. Banerjee, H.S. Vadiraj, A. Ram, R. Rao, M. Jayapal, K. S. Gopinath, B.S. Ramesh, N. Rao, A. Kumar, N. Raghuram, et al. Effects of an Integrated Yoga Program in Modulating Psychological Stress and Radiation-Induced Genotoxic Stress in Breast Cancer Patients Undergoing Radiotherapy Integr Cancer Ther, September 1, 2007; 6(3): 242 - 250. [Abstract] [PDF]

				A. E. Fonfa Patient Perspectives: Barriers to Complementary and Alternative Medicine Therapies Create Problems for Patients and Survivors Integr Cancer Ther, September 1, 2007; 6(3): 297 - 300. [Abstract] [PDF]

				K. M. Mustian, G. R. Morrow, J. K. Carroll, C. D. Figueroa-Moseley, P. Jean-Pierre, and G. C. Williams Integrative Nonpharmacologic Behavioral Interventions for the Management of Cancer-Related Fatigue Oncologist, May 1, 2007; 12(suppl_1): 52 - 67. [Abstract] [Full Text] [PDF]

				T. Mok, W Yeo, P. Johnson, P Hui, W. Ho, K. Lam, M Xu, K Chak, A Chan, H Wong, et al. A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity Ann. Onc., April 1, 2007; 18(4): 768 - 774. [Abstract] [Full Text] [PDF]

				J. K. Staples, A. T. Wilson, B. Pierce, and J. S. Gordon Effectiveness of CancerGuides(R): A Study of an Integrative Cancer Care Training Program for Health Professionals Integr Cancer Ther, March 1, 2007; 6(1): 14 - 24. [Abstract] [PDF]

				L. B. Michaud, J. P. Karpinski, K. L. Jones, and J. Espirito Dietary supplements in patients with cancer: Risks and key concepts, part 1 Am. J. Health Syst. Pharm., February 15, 2007; 64(4): 369 - 381. [Abstract] [Full Text] [PDF]

				F. J. Hlubocky, M. J. Ratain, M. Wen, and C. K. Daugherty Complementary and Alternative Medicine Among Advanced Cancer Patients Enrolled on Phase I Trials: A Study of Prognosis, Quality of Life, and Preferences for Decision Making J. Clin. Oncol., February 10, 2007; 25(5): 548 - 554. [Abstract] [Full Text] [PDF]

				A. Bardia, D. L. Barton, L. J. Prokop, B. A. Bauer, and T. J. Moynihan Efficacy of Complementary and Alternative Medicine Therapies in Relieving Cancer Pain: A Systematic Review J. Clin. Oncol., December 1, 2006; 24(34): 5457 - 5464. [Abstract] [Full Text] [PDF]

				A. L. Stanton Psychosocial Concerns and Interventions for Cancer Survivors J. Clin. Oncol., November 10, 2006; 24(32): 5132 - 5137. [Abstract] [Full Text] [PDF]

				A. Bardia, D. L. Wahner-Roedler, P. L. Erwin, and A. Sood Search Strategies for Retrieving Complementary and Alternative Medicine Clinical Trials in Oncology Integr Cancer Ther, September 1, 2006; 5(3): 202 - 205. [Abstract] [PDF]

				S. E. Lana, L. R. Kogan, K. A. Crump, J. T. Graham, and N. G. Robinson The use of complementary and alternative therapies in dogs and cats with cancer. J. Am. Anim. Hosp. Assoc., September 1, 2006; 42(5): 361 - 365. [Abstract] [Full Text] [PDF]

				J. Post-White Complementary and Alternative Medicine in Pediatric Oncology Journal of Pediatric Oncology Nursing, September 1, 2006; 23(5): 244 - 253. [Abstract] [PDF]

				J. Post-White, R. Hawks, A. O'Mara, and M. J. Ott Future Directions of CAM Research in Pediatric Oncology Journal of Pediatric Oncology Nursing, September 1, 2006; 23(5): 265 - 268. [Abstract] [PDF]

				M. Tascilar, F. A. de Jong, J. Verweij, and R. H. J. Mathijssen Complementary and Alternative Medicine During Cancer Treatment: Beyond Innocence Oncologist, July 1, 2006; 11(7): 732 - 741. [Abstract] [Full Text] [PDF]

				Y. Cui, X.-O. Shu, Y.-T. Gao, H. Cai, M.-H. Tao, and W. Zheng Association of Ginseng Use with Survival and Quality of Life among Breast Cancer Patients Am. J. Epidemiol., April 1, 2006; 163(7): 645 - 653. [Abstract] [Full Text] [PDF]

				L. M. DiGianni, M. Rue, K. Emmons, and J. E. Garber Complementary Medicine Use before and 1 Year Following Genetic Testing for BRCA1/2 Mutations Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 70 - 75. [Abstract] [Full Text] [PDF]

				M. J. Verhoef, L. G. Balneaves, H. S. Boon, and A. Vroegindewey Reasons for and Characteristics Associated With Complementary and Alternative Medicine Use Among Adult Cancer Patients: A Systematic Review Integr Cancer Ther, December 1, 2005; 4(4): 274 - 286. [Abstract] [PDF]

				N. P.H. van Erp, S. D. Baker, M. Zhao, M. A. Rudek, H.-J. Guchelaar, J. W.R. Nortier, A. Sparreboom, and H. Gelderblom Effect of Milk Thistle (Silybum marianum) on the Pharmacokinetics of Irinotecan Clin. Cancer Res., November 1, 2005; 11(21): 7800 - 7806. [Abstract] [Full Text] [PDF]

				N. Humpel and S. C. Jones Development of a Comprehensive Questionnaire of Complementary and Alternative Medicine Use Among Cancer Patients and Survivors Complementary Health Practice Review, October 1, 2005; 10(3): 163 - 174. [Abstract] [PDF]

				D. R. Buchanan, J. D. White, A. M. O'Mara, J. W. Kelaghan, W. B. Smith, and L. M. Minasian Research-Design Issues in Cancer-Symptom-Management Trials Using Complementary and Alternative Medicine: Lessons From the National Cancer Institute Community Clinical Oncology Program Experience J. Clin. Oncol., September 20, 2005; 23(27): 6682 - 6689. [Abstract] [Full Text] [PDF]

				A. J. Cohen, A. Menter, and L. Hale Acupuncture: Role in Comprehensive Cancer Care--A Primer for the Oncologist and Review of the Literature Integr Cancer Ther, June 1, 2005; 4(2): 131 - 143. [Abstract] [PDF]

				I. Hyodo, N. Amano, K. Eguchi, M. Narabayashi, J. Imanishi, M. Hirai, T. Nakano, and S. Takashima Nationwide Survey on Complementary and Alternative Medicine in Cancer Patients in Japan J. Clin. Oncol., April 20, 2005; 23(12): 2645 - 2654. [Abstract] [Full Text] [PDF]

				A. Molassiotis, P. Fernadez-Ortega, D. Pud, G. Ozden, J. A. Scott, V. Panteli, A. Margulies, M. Browall, M. Magri, S. Selvekerova, et al. Use of complementary and alternative medicine in cancer patients: a European survey Ann. Onc., April 1, 2005; 16(4): 655 - 663. [Abstract] [Full Text] [PDF]

				D. S. Rosenthal and E. Dean-Clower Integrative Medicine in Hematology/Oncology: Benefits, Ethical Considerations, and Controversies Hematology, January 1, 2005; 2005(1): 491 - 497. [Abstract] [Full Text] [PDF]

				S. D. Baker, R. H. N. van Schaik, L. P. Rivory, A. J. ten Tije, K. Dinh, W. J. Graveland, P. W. Schenk, K. A. Charles, S. J. Clarke, M. A. Carducci, et al. Factors Affecting Cytochrome P-450 3A Activity in Cancer Patients Clin. Cancer Res., December 15, 2004; 10(24): 8341 - 8350. [Abstract] [Full Text] [PDF]

				K. N. Prasad Multiple Dietary Antioxidants Enhance the Efficacy of Standard and Experimental Cancer Therapies and Decrease Their Toxicity Integr Cancer Ther, December 1, 2004; 3(4): 310 - 322. [Abstract] [PDF]

				G. K. Dy, L. Bekele, L. J. Hanson, A. Furth, S. Mandrekar, J. A. Sloan, and A. A. Adjei Complementary and Alternative Medicine Use by Patients Enrolled Onto Phase I Clinical Trials J. Clin. Oncol., December 1, 2004; 22(23): 4810 - 4815. [Abstract] [Full Text] [PDF]

				E. Ben-Arye and M. Frenkel An Approach to Teaching Physicians about Complementary Medicine in the Treatment of Cancer Integr Cancer Ther, September 1, 2004; 3(3): 208 - 213. [Abstract] [PDF]

				M. L de Lemos, L. John, L. Nakashima, R. K. O'Brien, and S. C. Taylor Advising Cancer Patients on Natural Health Products--A Structured Approach Ann. Pharmacother., September 1, 2004; 38(9): 1406 - 1411. [Abstract] [Full Text] [PDF]

				Y. Xue and S. S. Cohen Dietary Supplements: Policy and Research Implications for Nurses Policy Politics Nursing Practice, August 1, 2004; 5(3): 149 - 159. [Abstract] [PDF]

				A. Sparreboom, M. C. Cox, M. R. Acharya, and W. D. Figg Herbal Remedies in the United States: Potential Adverse Interactions With Anticancer Agents J. Clin. Oncol., June 15, 2004; 22(12): 2489 - 2503. [Abstract] [Full Text] [PDF]

				S.-M. Huang and L. J. Lesko Drug-Drug, Drug-Dietary Supplement, and Drug-Citrus Fruit and Other Food Interactions: What Have We Learned? J. Clin. Pharmacol., June 1, 2004; 44(6): 559 - 569. [Abstract] [Full Text] [PDF]

				M. A. Navo, J. Phan, C. Vaughan, J. L. Palmer, L. Michaud, K. L. Jones, D. C. Bodurka, K. Basen-Engquist, G. N. Hortobagyi, J. J. Kavanagh, et al. An Assessment of the Utilization of Complementary and Alternative Medication in Women With Gynecologic or Breast Malignancies J. Clin. Oncol., February 15, 2004; 22(4): 671 - 677. [Abstract] [Full Text] [PDF]

				B. R. Cassileth and G. Deng Complementary and Alternative Therapies for Cancer Oncologist, February 1, 2004; 9(1): 80 - 89. [Abstract] [Full Text] [PDF]

				H. Boon, J. B. Brown, A. Gavin, and K. Westlake Men with Prostate Cancer: Making Decisions about Complementary/Alternative Medicine Med Decis Making, November 1, 2003; 23(6): 471 - 479. [Abstract] [PDF]

				C. H. Takimoto, K. Glover, X. Huang, S. A. Hayes, L. Gallot, M. Quinn, B. D. Jovanovic, A. Shapiro, L. Hernandez, A. Goetz, et al. Phase I Pharmacokinetic and Pharmacodynamic Analysis of Unconjugated Soy Isoflavones Administered to Individuals with Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1213 - 1221. [Abstract] [Full Text]

				R. A. Johnson, R. L. Meadows, J. S. Haubner, and K. Sevedge Human-Animal Interaction: A Complementary/Alternative Medical (CAM) Intervention for Cancer Patients American Behavioral Scientist, September 1, 2003; 47(1): 55 - 69. [Abstract] [PDF]

				T. G Burnakis Comment: usefulness of herbal and dietary supplement references Ann. Pharmacother., September 1, 2003; 37(9): 1346 - 1346. [Full Text] [PDF]

				H. E. Seifried, S. S. McDonald, D. E. Anderson, P. Greenwald, and J. A. Milner The Antioxidant Conundrum in Cancer Cancer Res., August 1, 2003; 63(15): 4295 - 4298. [Abstract] [Full Text] [PDF]

				L. M. DiGianni, H. T. Kim, K. Emmons, R. Gelman, K. J. Kalkbrenner, and J. E. Garber Complementary Medicine Use among Women Enrolled in a Genetic Testing Program Cancer Epidemiol. Biomarkers Prev., April 1, 2003; 12(4): 321 - 326. [Abstract] [Full Text] [PDF]

				J. A. Drisko, J. Chapman, and V. J. Hunter The Use of Antioxidants with First-Line Chemotherapy in Two Cases of Ovarian Cancer J. Am. Coll. Nutr., April 1, 2003; 22(2): 118 - 123. [Abstract] [Full Text] [PDF]

				M. M. Lee, J. S. Chang, B. Jacobs, and M. R. Wrensch Complementary and Alternative Medicine Use Among Men With Prostate Cancer in 4 Ethnic Populations Am J Public Health, October 1, 2002; 92(10): 1606 - 1609. [Full Text] [PDF]

				L. M. DiGianni, J. E. Garber, and E. P. Winer Complementary and Alternative Medicine Use Among Women With Breast Cancer J. Clin. Oncol., September 15, 2002; 20(90001): 34s - 38. [Abstract] [Full Text] [PDF]

				M. Markman Safety Issues in Using Complementary and Alternative Medicine J. Clin. Oncol., September 15, 2002; 20(90001): 39s - 41. [Abstract] [Full Text] [PDF]

				G. A. Cordell PC-SPES: A Brief Overview Integr Cancer Ther, September 1, 2002; 1(3): 271 - 286. [Abstract] [PDF]

				P. J. Mansky and S. E. Straus St. John's Wort: More Implications for Cancer Patients J Natl Cancer Inst, August 21, 2002; 94(16): 1187 - 1188. [Full Text] [PDF]

				R. J. Cohen, K. Ek, and C. X. Pan Complementary and Alternative Medicine (CAM) Use by Older Adults: A Comparison of Self-Report and Physician Chart Documentation J. Gerontol. A Biol. Sci. Med. Sci., April 1, 2002; 57(4): M223 - 227. [Abstract] [Full Text] [PDF]

				M. S. Goldstein The Emerging Socioeconomic and Political Support for Alternative Medicine in the United States The ANNALS of the American Academy of Political and Social Science, January 1, 2002; 583(1): 44 - 63. [Abstract] [PDF]

				M. J. Wargovich, C. Woods, D. M. Hollis, and M. E. Zander Herbals, Cancer Prevention and Health J. Nutr., November 1, 2001; 131(11): 3034S - 3036. [Abstract] [Full Text] [PDF]

				M. A. Richardson Biopharmacologic and Herbal Therapies for Cancer: Research Update from NCCAM J. Nutr., November 1, 2001; 131(11): 3037S - 3040. [Abstract] [Full Text] [PDF]

				R. T. Penson, C. M. Castro, M. V. Seiden, B. A. Chabner, and T. J. Lynch Jr. Complementary, Alternative, Integrative, or Unconventional Medicine? Oncologist, October 1, 2001; 6(5): 463 - 473. [Abstract] [Full Text] [PDF]

				M. Markman Interactions Between Academic Oncology and Alternative/Complementary/Integrative Medicine: Complex But Necessary J. Clin. Oncol., September 15, 2001; 19(90001): 52s - 53. [Full Text] [PDF]

				O. Paltiel, M. Avitzour, T. Peretz, N. Cherny, L. Kaduri, R. M. Pfeffer, N. Wagner, and V. Soskolne Determinants of the Use of Complementary Therapies by Patients With Cancer J. Clin. Oncol., May 1, 2001; 19(9): 2439 - 2448. [Abstract] [Full Text] [PDF]

				L. R. Prosnitz Complemenary Therapies in Cancer Patients J. Clin. Oncol., January 15, 2001; 19(2): 598 - 598. [Full Text] [PDF]

				S. M. Grunberg Stage Shift and Complementary/Alternative Medicine J. Clin. Oncol., October 19, 2000; 18(19): 3455 - 3456. [Full Text] [PDF]

				H. J. Burstein Discussing Complementary Therapies With Cancer Patients: What Should We Be Talking About? J. Clin. Oncol., July 1, 2000; 18(13): 2501 - 2504. [Full Text] [PDF]